Endovascular Engineering, Inc. (E2) is a venture-backed medical device company developing next-generation clot-removal technologies for venous thromboembolism. Its Hēlo™ Thrombectomy System combines high-speed agitation with physician-controlled aspiration for pulmonary embolism treatment.